Bartlett & Co Wealth Management’s Vaxart VXRT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-200
Closed -$90 1278
2025
Q2
$90 Hold
200
﹤0.01% 1232
2025
Q1
$81 Hold
200
﹤0.01% 1212
2024
Q4
$132 Hold
200
﹤0.01% 1106
2024
Q3
$170 Hold
200
﹤0.01% 1107
2024
Q2
$133 Hold
200
﹤0.01% 1118
2024
Q1
$260 Hold
200
﹤0.01% 1099
2023
Q4
$114 Hold
200
﹤0.01% 1223
2023
Q3
$151 Hold
200
﹤0.01% 1155
2023
Q2
$146 Hold
200
﹤0.01% 1134
2023
Q1
$151 Hold
200
﹤0.01% 1050
2022
Q4
$192 Hold
200
﹤0.01% 1083
2022
Q3
$436 Hold
200
﹤0.01% 1149
2022
Q2
$700 Hold
200
﹤0.01% 1256
2022
Q1
$1.01K Buy
+200
New +$1.01K ﹤0.01% 1023
2021
Q4
Sell
-200
Closed -$1.59K 880
2021
Q3
$1.59K Hold
200
﹤0.01% 891
2021
Q2
$1.5K Hold
200
﹤0.01% 897
2021
Q1
$1.21K Buy
+200
New +$1.54K ﹤0.01% 952

Other funds holding VXRT

Bartlett & Co Wealth Management's VXRT Position: Q3 2025 in Review

Bartlett & Co Wealth Management sold out of Vaxart (VXRT) in Q3 2025, closing a stake of 200 shares — an estimated $90 sold.

Bartlett & Co Wealth Management first reported a position in VXRT in Q1 2021 and held it in 17 quarters. The position peaked at $1.59K in Q3 2021. 17 funds tracked by Wall St. Rank hold VXRT as of Q3 2025.

  • Bartlett & Co Wealth Management reported no remaining Vaxart position as of Q3 2025 after selling out during the quarter.
  • Bartlett & Co Wealth Management sold 200 Vaxart shares in Q3 2025, an estimated $90.
  • Bartlett & Co Wealth Management first reported a position in Vaxart in Q1 2021 and held it in 17 quarters.
  • Bartlett & Co Wealth Management's Vaxart position peaked at $1.59K in Q3 2021.
  • 17 funds tracked by Wall St. Rank held Vaxart as of Q3 2025.

Based on Bartlett & Co Wealth Management's 13F filing for Q3 2025, filed 9 Oct 2025.